Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
StrongBone
NCT07191353Phase 2Recruiting
- Sponsor
- University Hospital Odense
- Start
- Oct 2025
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of everolimus in osteopenia, sponsored by University Hospital Odense. Started Oct 2025; status: recruiting.
02
Drugs
everolimus
03
Conditions
osteopenia
Beyond the preview
Go deeper on NCT07191353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07191353.